Medtronic (NYSE:MDT) revealed its plans for an incubation and acceleration platform for innovation in the neurovascular space.
In a presentation yesterday at DeviceTalks West in Santa Clara, California, the company unveiled its plan to bring innovations to market to address strokes. Daniel Volz, president of Medtronic Neurovascular, and Derek Crittenden, Medtronic’s new technology & strategy program manager, presented the news.
Image: Dan Volz (right) and Derek Crittenden (left) present the Medtronic Co-Lab program at DeviceTalks West in Santa Clara, California. – https://www.massdevice.com
{iframe}https://www.massdevice.com/medtronic-unveils-neurovascular-innovation-incubator/{/iframe}